Archived 6 years ago from Natural NewsChinese pharmaceutical firm Sinovac gets $500 million, boosting its coronavirus vaccine production
Chinese drugmaker Sinovac Biotech has obtained a cash investment to help boost production of its COVID-19 vaccine. Generic drugs firm Sino Biopharmaceuticals announced on Dec. 7 that it acquired a 15 percent stake in Sinovac Life Sciences, the subsidiary in charge of vaccine manufacturing. Sinovac …
Read More